Alliance Global Partners Comments on Curaleaf Q3 Earnings

Key Points

• Alliance Global Partners has revised Curaleaf's Q3 2025 earnings forecast, lowering it to ($0.07) per share from the previous estimate of ($0.06).
• Cormark has upgraded Curaleaf’s stock rating from "hold" to a "moderate buy" as of Friday.
• Curaleaf reported a EPS of ($0.06) for the last quarter, beating analysts' expectations by $0.01.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Free Report) - Alliance Global Partners decreased their Q3 2025 earnings per share (EPS) estimates for shares of Curaleaf in a report released on Thursday, August 7th. Alliance Global Partners analyst A. Grey now anticipates that the company will post earnings of ($0.07) per share for the quarter, down from their prior forecast of ($0.06). The consensus estimate for Curaleaf's current full-year earnings is ($0.25) per share. Alliance Global Partners also issued estimates for Curaleaf's FY2025 earnings at ($0.29) EPS.

Separately, Cormark upgraded Curaleaf from a "hold" rating to a "moderate buy" rating in a research note on Friday, August 8th.

Curaleaf Trading Down 2.9%

CURLF stock traded down $0.09 during midday trading on Monday, reaching $2.99. The company's stock had a trading volume of 1,210,136 shares, compared to its average volume of 758,509. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.70 and a current ratio of 1.47. The stock has a fifty day simple moving average of $1.19 and a two-hundred day simple moving average of $1.09. Curaleaf has a 1 year low of $0.68 and a 1 year high of $3.58. The firm has a market capitalization of $2.01 billion, a price-to-earnings ratio of -9.35 and a beta of 0.69.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.